Obesity and cardiovascular outcomes: a review (Q38187956)

30 August 2017

Obesity and cardiovascular outcomes: a review (English)

1 reference

30 August 2017

0 references

Kuldeepa Ghoorah

1

1 reference

30 August 2017

Peter Campbell

2

1 reference

30 August 2017

Alexandra Kent

3

1 reference

30 August 2017

Annette Maznyczka

4

1 reference

30 August 2017

Vijay Kunadian

5

1 reference

30 August 2017

13 February 2014

1 reference

European heart journal. Acute cardiovascular care

30 August 2017

1 reference

30 August 2017

5

1 reference

30 August 2017

77-85

1 reference

30 August 2017

1

1 reference

Obesity: impact of cardiovascular disease.

30 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

The obesity paradox in men versus women with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Effect of Obesity on Short- and Long-term Mortality Postcoronary Revascularization: A Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Impact of body mass index in the results after primary angioplasty in patients with ST segment elevation acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus- and Sirolimus-eluting stents (from the LEADERS Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drug-eluting stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Current concepts of the pathogenesis of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Biomechanical factors and macrophages in plaque stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Association of coronary plaque composition and arterial remodelling: a optical coherence tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Severity of coronary artery disease in obese patients undergoing coronary angiography: "obesity paradox" revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Calcification in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

The relationship between C-reactive protein and atherosclerosis differs on the basis of body mass index: the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Sex differences in the relationship between C-reactive protein and body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Adiposity, inflammation, and risk for death in black and white men and women in the United States: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

The obesity paradox and myocardial infarct size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Association between obesity and infarct size: insight into the obesity paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Obesity and age of first non-ST-segment elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Gender differences in clinical status at time of coronary revascularisation in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Mechanisms linking obesity with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Obesity accelerates the progression of coronary atherosclerosis in young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Effects of Obesity on Lipid-Lowering, Anti-Inflammatory, and Antiatherosclerotic Benefits of Atorvastatin or Pravastatin in Patients With Coronary Artery Disease (from the REVERSAL Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

Paradoxical Preservation of Vascular Function in Severe Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2048872614523349

21 January 2018

Identifiers

DOI

10.1177/2048872614523349

1 reference

30 August 2017

1 reference